EMEA-002886-PIP01-20
Key facts
| Active substance |
Human, recombinant, non-fucosylated IgG1k monoclonal antibody targeting OX-40 receptor on activated T cells (KHK4083)
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0320/2021
|
| PIP number |
EMEA-002886-PIP01-20
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of atopic dermatitis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Kyowa Kirin Pharmaceutical Development Limited
Tel. +44 1896664000 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|